(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) 2021 ´ëÇѺñ¸¸ÇÐȸ Á¦53Â÷ Ãá°èÇмú´ëȸ : 2021-03-27±³À°ÀÏÀÚ : 2021-03-27
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ (*¿ÀÇÁ¶óÀÎ: ½¦¶óÅæ ¼¿ï µðÅ¥ºê½ÃƼ È£ÅÚ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) 2021 ´ëÇѺñ¸¸ÇÐȸ Á¦53Â÷ Ãá°èÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇѺñ¸¸ÇÐȸ
´ã´çÀÚ : ¾ÈÇýÀº
¿¬¶ôó : 02-6941-0888
À̸ÞÀÏ :
obesity@kosso.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, °¡Á¤ÀÇÇаúÇغÎÇÐ, »ýÈÇÐ,
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 14 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëA 08:30~09:20 Treatment of Early Combination Therapy in T2DM Patients; GEMIGLIPTIN ÀÌÀçÇõ(¸íÁöº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëA 09:30~09:50 Effects of climatic factors and air pollution on obesity ÀÌ»ó¿(°æÈñÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëA 09:50~10:10 Urban neighborhood environment, physical activity, and obesity ÀÌÇýÁø(¼¿ïÀÇ´ë °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëA 10:10~10:30 Exposure to unhealthy food outlets within residential district and obesity ÇѼº¸²(¼¿ï´ë ¿µ¾çÇаú)
Åä·Ð 03¿ù 27ÀÏ ±×·£µåº¼·ëA 10:30~11:00 ÆгÎÅäÀÇ À̽Âȯ(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëB 09:30~09:50 Warm on a cold night: neural basis of behavioral thermoregulation ±è¼º¿¬(¼¿ï´ë ÀÚ¿¬´ë)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëB 09:50~10:10 Comprehensive functional imaging on taste sensation in vivo ÃÖ¸íȯ(¼¿ï´ë ÀÚ¿¬´ë)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëB 10:10~10:30 hypothalamic development and postnatal energy balance À̺¸¶ó(Àü³²ÀÇ´ë)
Åä·Ð 03¿ù 27ÀÏ ±×·£µåº¼·ëB 10:30~11:00 ÆгÎÅäÀÇ ±Ç¿Àºó(¼¿ïÀÇ´ë »ýÈÇб³½Ç)
±³À°½Ã°£ 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 09:30~09:50 single cell RNAseq ±èÁ¾°æ(DGIST)
±³À°½Ã°£ 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 09:50~10:10 ´ë»çÁúȯ ¿¬±¸¸¦ À§ÇÑ ¸ÖƼ¿À¹Í½º Ç÷§Æû ±¸Ãà ±Ç¼º¿ø(¼¿ï´ë ¾à´ë)
±³À°½Ã°£ 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 10:10~10:30 proteomics ±è°æ°ï(¿ï»êÀÇ´ë ¾Æ»ê»ý¸í°úÇבּ¸¿ø)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ë 11:20~12:00 Precision medicine in obesity and the value of genetic information Ruth J.F. Loos(Icahn School of Medicine, USA)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ë 12:00~12:25 Obesity treatment with Phentermine plus Topiramate ER in patients with comorbidities ÀüÇýÁø(ºÐ´çÂ÷º´¿ø °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ë 12:25~12:50 The latest evidence of SGLT2I for type 2 Diabetes patients ±è´ëÁß(¾ÆÁÖÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëA 14:00~14:20 Adipocyte biology and obesity ±èÀç¹ü(¼¿ï´ë »ý¸í°úÇкÎ)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëA 14:20~14:40 Integrative role of hypothalamus in the control of energy balance ±è±â¿ì(¿¬¼¼´ë Ä¡°ú´ëÇÐ)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëA 14:40~15:00 Endocrine crosstalk between skeletal muscle and other endocrine organs ÀÌÇö½Â(Ãæ³²ÀÇ´ë ³»ºÐºñ³»°ú)
Åä·Ð 03¿ù 27ÀÏ ±×·£µåº¼·ëA 15:00~15:30 ÆгÎÅäÀÇ ¼ÕÀå¿ø(°¡Å縯ÀÇ´ë ºÎõ¼º¸ðº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëB 14:00~14:20 New options for management of obese patients with NAFLD È«ÁØÈ(À»ÁöÀÇ´ë ´ëÀüÀ»Áö´ëº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëB 14:20~14:40 Best practice for obese patients with type 2 diabetes Àü¼÷(°æÈñÀÇ´ë °æÈñ´ëº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëB 14:40~15:00 Measurement and management of sarcopenic obesity in elderly °ÁöÇö(°Ç¾çÀÇ´ë °Ç¾ç´ëº´¿ø °¡Á¤ÀÇÇаú)
Åä·Ð 03¿ù 27ÀÏ ±×·£µåº¼·ëB 15:00~15:30 ÆгÎÅäÀÇ ¹®Áؼº(¿µ³²ÀÇ´ë ¿µ³²´ëº´¿ø ³»ºÐºñ´ë»ç³»°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 14:00~14:20 Multidimensional Cognitive Behavioral Therapy for Obesity Using Digital Therapeutics ÃÖÇüÁø(¼¿ïÀÇ´ë ÇغÎÇб³½Ç)
±³À°½Ã°£ 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 14:20~14:40 Metabolic syndrome management using RWD °¼ºÁö(À£Æ®)
±³À°½Ã°£ 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 14:40~15:00 Real industrial issues of digital therapeutics ±è¼öÁø(¿¡ÀÓ¸Þµå)
Åä·Ð 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 15:00~15:30 ÆгÎÅäÀÇ ÀÌ»ó¿(°æÈñÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëA 15:50~16:10 Surgical Management ¹ÚÁö¿¬(°æºÏÀÇ´ë Ä¥°î°æºÏ´ëº´¿ø ¿Ü°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëA 16:10~16:30 Medical Management ÀÓÁö¼±(H+ ¾çÁöº´¿ø °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëA 16:30~16:50 Various case scenario Á¤À±¾Æ(H+ ¾çÁöº´¿ø ¿Ü°ú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëB 15:50~16:10 Senescence and muscle metabolism ·ùµ¿·Ä(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëB 16:10~16:30 Role of exercise in sarcopenia obesity-induced mitochondrial dysfunction in the rat skeletal muscle °ûÈ¿¹ü(ÀÎÇÏ´ë üÀ°Çаú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëB 16:30~16:50 Sarcopenic obesity and Nutrition ÀÌÇØÁ¤(°¡Ãµ´ë ½ÄÇ°¿µ¾çÇаú)
±³À°½Ã°£ 03¿ù 27ÀÏ ±×·£µåº¼·ëB 16:50~17:10 Effects of resistance exercise training, dietary amino acids, or combination on muscle mass/quality and insulin resistance ÀåÁö¿õ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 15:50~16:10 Impact of obesity and metaboli dysfunction on the COVID-19: Experience of Daegu city ±è¹Ì°æ(°è¸íÀÇ´ë)
±³À°½Ã°£ 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 16:10~16:30 Impact of obesity on the severity of COVID-19: A matter of sexual dimorphism? Á¤ÀçÈÆ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 16:30~16:50 How to Manage the Obesity and Metabolic disorders in COVID-19 era. ¹èÀçÇö(°í·ÁÀÇ´ë)
Åä·Ð 03¿ù 27ÀÏ °¡µå´Ï¾Æ&Ä®¶ó 16:50~17:20 ÆгÎÅäÀÇ ¹®Áؼº(¿µ³²ÀÇ´ë)